Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Investigating the Inhibitory Effects of Hydatid Cyst Fluid and its Antigens on Cancer Progression: A Review

Version 1 : Received: 29 July 2023 / Approved: 31 July 2023 / Online: 1 August 2023 (02:54:51 CEST)

How to cite: Shojaeian, A.; Barati, N.; Motavallihaghi, S. Investigating the Inhibitory Effects of Hydatid Cyst Fluid and its Antigens on Cancer Progression: A Review. Preprints 2023, 2023072141. https://doi.org/10.20944/preprints202307.2141.v1 Shojaeian, A.; Barati, N.; Motavallihaghi, S. Investigating the Inhibitory Effects of Hydatid Cyst Fluid and its Antigens on Cancer Progression: A Review. Preprints 2023, 2023072141. https://doi.org/10.20944/preprints202307.2141.v1

Abstract

Hydatid cyst fluid is a complex biological substance consisting primarily of water, proteins, lipids, carbohydrates, salts, enzymes, hormones, growth factors, immune modulators, and other bioactive molecules. Antigens, including antigen B (AgB) and antigen 5 family members (Ag5), have been identified in hydatid cyst fluid and have been shown to have the ability to inhibit cancer progression. The exact mechanisms by which these components exert inhibitory effects on cancer progression are not fully understood, but it is believed that they may influence multiple signaling pathways involved in cell proliferation, survival, angiogenesis, and metastasis. In vitro studies have demonstrated that treatment with hydatid cyst fluid or specific antigens can inhibit cell growth, induce apoptosis, and suppress the migration of cancer cells. Animal model studies have also demonstrated significant inhibition of tumor growth, reduction in angiogenesis, and suppression of metastasis. Limited clinical studies have shown promising outcomes, including improved overall survival and reduced recurrence rates among breast cancer patients receiving AgB immunotherapy alongside standard treatment.

Keywords

Hydatid cyst fluid; Antigen; Cancer inhibition; Apoptosis; Metastasis

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.